GLOBAL HIV VACCINE ENTERPRISE
$1,077,813N01FY2013AINIH
Global Hiv Vaccine Enterprise, New York NY
Investigators
Abstract
This contract provides funds for the Global HIV Vaccine Enterprise to develop a scientific strategic plan for HIV/AIDS research.
View original record on NIH RePORTER →